Austin Carol, Pettit Simon N, Magnolo Sharon K, Sanvoisin Jonathan, Chen Wenjie, Wood Stephen P, Freeman Lauren D, Pengelly Reuben J, Hughes Dallas E
Discovery, Selcia Ltd, Fyfield Business and Research Park, Ongar, UK.
J Biomol Screen. 2012 Aug;17(7):868-76. doi: 10.1177/1087057112445785. Epub 2012 May 9.
CEfrag is a new fragment screening technology based on affinity capillary electrophoresis (ACE). Here we report on the development of a mobility shift competition assay using full-length human heat shock protein 90α (Hsp90α), radicicol as the competitor probe ligand, and successful screening of the Selcia fragment library. The CEfrag assay was able to detect weaker affinity (IC(50) >500 µM) fragments than were detected by a fluorescence polarization competition assay using FITC-labeled geldanamycin. The binding site of selected fragments was determined by co-crystallization with recombinant Hsp90α N-terminal domain and X-ray analysis. The results of this study confirm that CEfrag is a sensitive microscale technique enabling detection of fragments binding to the biological target in near-physiological solution.
CEfrag是一种基于亲和毛细管电泳(ACE)的新型片段筛选技术。在此,我们报告了一种迁移率变化竞争分析方法的开发,该方法使用全长人热休克蛋白90α(Hsp90α)、萝卜硫素作为竞争探针配体,并成功筛选了Selcia片段文库。与使用异硫氰酸荧光素(FITC)标记的格尔德霉素的荧光偏振竞争分析相比,CEfrag分析能够检测到亲和力较弱(IC(50)>500µM)的片段。通过与重组Hsp90αN端结构域共结晶和X射线分析确定了所选片段的结合位点。本研究结果证实,CEfrag是一种灵敏的微量技术,能够在接近生理溶液中检测与生物靶点结合的片段。